Objective This study aims to analyze clinical data collected from patients with positive accidental antibody screening results, exploring the distribution of accidental antibodies and their correlation with transfusion history and pregnancy history, providing a reference basis for ensuring clinical transfusion safety. Methods This research collected clinical data from patients with positive and negative accidental antibody screening results at Xiangya Third Hospital of Central South University from April 2020 to March 2021, and conducted a retrospective analysis. Results Among the 116 patients, 66 cases of accidental antibody positivity were identified after excluding incomplete data, including 19 males and 47 females. Accidental antibodies were mainly distributed in the Rh system, with anti-E being the most common, accounting for 30.3%; the Lewis blood group system accounted for 18.18%, with some patients exhibiting both anti-Lea and anti-Leb; in the MNS blood group system, anti-M accounted for 13.64% and anti-Mur antibodies accounted for 9.09%. Additionally, autoantibodies accounted for 3.03%, mixed antibodies accounted for 1.52%, and specific antibodies not detected accounted for 1.52%. Gender, transfusion history, and pregnancy history were statistically significant factors in the detection rate of accidental antibodies. Furthermore, multivariable logistic regression analysis indicated that a history of transfusion and pregnancy were independent risk factors for the production of accidental antibodies. Conclusion The detection rate of anti-E in the Rh blood group system is the highest, which requires attention. It is recommended to establish a Rh blood group system donor phenotype database to provide safer and faster transfusion treatment for patients.
Key words
antibody screening /
transfusion history /
pregnancy history /
blood transfusion safety
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 刘利祥. ABO、Rh血型相关调查及建立Rh表型库在安全输血中的重要意义[D]. 天津: 天津医科大学, 2016.
[2] 顾小文, 邓之奎.44例疑难血型处理策略与结果分析[J]. 标记免疫分析与临床, 2024, 31(8): 1522-1528.
[3] 郑兆丽, 刘静, 程雪梅.51例ABO正反定型不符原因分析及解决方法[J]. 中国当代医药, 2021, 28(29): 170-173.
[4] 黄秀凤, 颜沛云, 庄大造, 等. 输血不良反应的特点及影响因素分析[J]. 中外医学研究, 2022, 20(09): 170-173.
[5] 粟明丽, 宁芳, 陈宇, 等.7596例患者血清不规则抗体分析与临床意义[J]. 细胞与分子免疫学杂志, 2015, 31(01): 103-104.
[6] 梁晓敏, 柳叶.3082例住院患者血清不规则抗体分布情况及影响因素分析[J]. 检验医学与临床, 2022, 19(05): 642-644.
[7] 罗俊轩, 梁倩妮, 罗斯威, 等. 输血前不规则抗体鉴定结果分析与临床输血安全[J]. 广州医药, 2025, 56(08): 1087-1093.
[8] 李娜, 杨世明, 穆士杰. 住院患者86672例红细胞不规则抗体筛查结果及特异性抗体分布特点[J]. 空军军医大学学报, 2022, 43(08): 875-878.
[9] OWAIDAH AY, NAFFAA NM, ALUMRAN A, et al.Phenotype frequencies of major blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) among blood donors in the Eastern region of Saudi Arabia[J]. J Blood Med, 2020, 11: 59-65.
[10] 颜天明, 徐慧群. 人群中不规则抗体的阳性率及与临床安全输血的关系探讨[J]. 中国卫生标准管理, 2020, 11(09): 114-116.
[11] 苏湘晖, 陈宏伟, 谭涛, 等. 岳阳地区无偿献血者RhCE、MNS、Kidd、Duffy血型系统调查及稀有血型库的建立[J]. 中国误诊学杂志, 2020, 15(05): 217-220.
[12] 王琛, 焦琴, 杨世明, 等.81例抗M抗体的鉴定及其对血型血清学检测的影响[J]. 细胞与分子免疫学杂志, 2022, 38(01): 74-77.
[13] COHN CS, DELANEY M, JOHNSON ST, et al.Technical Manual[M].20th ed. Bethesda: American Association of Blood Banks (AABB), 2020.
[14] 符小玲, 蔡兴权, 赵兴丹, 等. 海南黎族人群MNS和Mur血型系统基因频率分布及与其他民族人群比较[J]. 中国公共卫生, 2022, 38(6): 775-778.
[15] POLITOU M, VALSAMI S, DRYLLIS G, et al.Retrospective study on prevalence, specificity, sex, and age distribution of alloimmunization in two general hospitals in Athens[J]. Turk J Haematol, 2020, 37(3): 154-166.
[16] 丁冬明, 彭科琴, 许琳利. 受血者不规则抗体筛查在临床安全输血中的意义[J]. 中国实用医药, 2020, 15(35): 91-93.
[17] 中华人民共和国国家卫生健康委员会. 输血相容性检测标准: WS/T 794-2022[S]. 北京: 中华人民共和国国家卫生健康委员会, 2022.